中国P站

Exercise training; Cardiovascular disease; Cardiac amyloidosis; Heart failure with preserved ejection fraction; Atrial fibrillation; Hypertrophic cardiomyopathy; Coronary artery disease; Cardiac rehabilitation; Congenital heart disease; Older adults; Physical activity

Introduction

Exercise training is a cornerstone in managing various cardiovascular conditions, providing significant benefits across a spectrum of patient populations. For patients diagnosed with cardiac amyloidosis, comprehensive guidance outlines the safety and efficacy of tailored exercise prescriptions. These programs are designed based on individual functional capacity and disease severity, with the primary aim of enhancing quality of life and improving overall physical function[1].

Similarly, critical recommendations exist for exercise training in patients living with heart failure with preserved ejection fraction (HFpEF). This involves individualized exercise regimens focused on boosting exercise capacity, alleviating symptoms, and improving the quality of life for individuals facing this challenging condition[2].

The evidence base also extends to individuals with atrial fibrillation, where reviews summarize the benefits and safety of exercise. Practical guidance is provided for both clinicians and patients, defining appropriate exercise levels and modalities to emphasize improved cardiovascular health and effective symptom management[3].

In cases of hypertrophic cardiomyopathy (HCM), authoritative statements offer evidence-based guidance on safe and effective exercise participation. This addresses the historical restrictions on physical activity for HCM patients, helping them navigate the complexities of incorporating exercise into their lives[4].

Beyond condition-specific guidelines, a broader understanding of exercise's influence on cardiovascular diseases is emerging. Comprehensive reviews delve into how exercise affects the development and management of various conditions, highlighting the physiological mechanisms through which regular physical activity confers cardioprotective benefits and suggesting future research avenues[5].

For patients with coronary artery disease, systematic reviews and meta-analyses consolidate strong evidence regarding the effectiveness of exercise-based cardiac rehabilitation. These studies quantify the benefits of structured exercise programs on clinical outcomes, reinforcing their vital role in secondary prevention strategies[6].

The role of exercise in chronic coronary syndromes is also well-documented through clinical reviews. These reviews explore the physiological rationale for exercise therapy, offer practical considerations for exercise prescription, and highlight robust evidence supporting its advantages in improving cardiovascular function and overall patient prognosis[7].

Furthermore, research synthesizes available information on cardiac rehabilitation and exercise training for adults with congenital heart disease. This addresses a critical need for structured activity guidelines, evaluating the efficacy and safety of exercise interventions for this unique patient demographic[8].

Investigating the impact of different exercise modalities on cardiovascular health, particularly in older adults, systematic reviews and meta-analyses compare aerobic, resistance, and combined training. These insights are crucial for developing optimal exercise prescriptions to promote heart health in the aging population[9].

In summary, the pervasive importance of physical activity and exercise in both preventing and treating cardiovascular diseases is continuously being affirmed. Current reviews synthesize evidence, elucidate the mechanisms behind exercise’s beneficial effects, and provide practical advice for integrating it into clinical practice for a healthy heart[10].

Description

Exercise is increasingly recognized as a vital component in the comprehensive management of cardiovascular diseases. For patients with cardiac amyloidosis, specific guidelines from the American Heart Association detail safe and effective exercise training. These guidelines underscore the necessity of personalizing exercise regimens to align with an individual’s functional capacity and the severity of their disease, ultimately aiming to enhance their quality of life and physical capabilities [1]. This tailored approach ensures that patients receive the most beneficial intervention while minimizing risks.

Similarly, heart failure with preserved ejection fraction (HFpEF) demands careful consideration when it comes to physical activity. Recommendations advocate for individualized exercise programs designed to improve exercise capacity, alleviate symptoms, and significantly boost the quality of life for these patients [2]. Moreover, individuals with atrial fibrillation can greatly benefit from exercise, with evidence suggesting improvements in cardiovascular health and better symptom control. Clinicians are provided with practical guidance on suitable exercise levels and modalities to support these patients effectively [3].

The complexities of hypertrophic cardiomyopathy (HCM), a condition often associated with activity restrictions, are also addressed through authoritative statements. These statements provide evidence-based guidance to enable safe and effective exercise participation, helping patients and healthcare providers navigate physical activity with confidence [4]. Beyond specific conditions, broader research explores the fundamental role of exercise in cardiovascular health. A comprehensive review highlights how regular physical activity influences the development and management of various cardiovascular diseases, detailing the physiological mechanisms that confer cardioprotective benefits and pointing towards future research directions [5].

In the realm of secondary prevention, exercise-based cardiac rehabilitation is a powerful intervention for patients with coronary artery disease. A systematic review and meta-analysis consolidates robust evidence from randomized controlled trials, quantifying the clinical benefits of structured exercise programs and solidifying their essential role in patient recovery and long-term health [6]. This rehabilitation extends to chronic coronary syndromes, where clinical reviews examine the physiological basis for exercise therapy, provide practical advice for prescription, and emphasize its documented benefits in enhancing cardiovascular function and patient prognosis [7].

Addressing a unique population, a systematic review synthesizes research on cardiac rehabilitation and exercise training for adults with congenital heart disease. This review evaluates the safety and efficacy of exercise interventions, fulfilling a critical need for structured activity guidelines tailored to this group [8]. Furthermore, the effects of different exercise modalities on cardiovascular health in older adults have been investigated through systematic reviews and meta-analyses. These studies compare aerobic, resistance, and combined training, offering valuable insights into optimal exercise prescriptions to maintain and improve heart health in the aging population [9]. The overarching message from current literature is clear: physical activity and exercise are indispensable for both the prevention and treatment of cardiovascular diseases. Reviews synthesize existing evidence, clarify the mechanisms of action, and provide actionable advice for integrating exercise into routine clinical practice for a healthy heart [10].

Conclusion

Recent scientific statements and reviews underscore the critical role of exercise in both preventing and managing various cardiovascular diseases. Tailored exercise prescriptions are highlighted for conditions like cardiac amyloidosis, emphasizing individualized programs based on functional capacity and disease severity to improve quality of life and physical function. For heart failure with preserved ejection fraction (HFpEF), specific recommendations emphasize personalized exercise regimens to enhance capacity, reduce symptoms, and improve overall patient well-being. Individuals with atrial fibrillation benefit from exercise through improved cardiovascular health and symptom management, with practical guidance for clinicians and patients on appropriate activity levels. Navigating exercise in hypertrophic cardiomyopathy (HCM) involves evidence-based guidelines to ensure safe and effective participation, addressing historical activity restrictions. Beyond specific conditions, broader reviews explore the physiological mechanisms of cardioprotective benefits from regular physical activity, outlining current perspectives and future research. Exercise-based cardiac rehabilitation proves effective for coronary artery disease, reinforcing its role in secondary prevention through structured programs. Its benefits extend to chronic coronary syndromes, where exercise therapy improves cardiovascular function and patient prognosis. Furthermore, structured activity guidelines are crucial for adults with congenital heart disease, enhancing efficacy and safety. Research also delves into optimal exercise modalities for older adults, comparing aerobic, resistance, and combined training to promote heart health in the aging population. Collectively, these studies synthesize current evidence, affirming exercise as a cornerstone in cardiovascular disease prevention and treatment, and offer practical advice for its integration into clinical practice.

References

• Ambarish P, Marwa ASS, Khadijah B (2023) .Circulation 148:e198-e215.

, ,

• Barry AB, Pamela DT, Bethany FB (2023) .Circulation 147:e752-e765.

, ,

• David RY, William RB, Elizabeth VG (2023) .Circulation 147:e458-e478.

, ,

• Benjamin DL, Elizabeth VG, Leslie EG (2023) .Circulation 147:e428-e457.

, ,

• Alessandro G, Fabio F, Francesco D (2021) .J Clin Med 10:3045.

, ,

• Wei Z, Shu-Xia W, Xiang-Mei Z (2021) .Eur J Prev Cardiol 28:99-110.

, ,

• Gianluca V, Matteo LP, Mattia B (2022) .J Clin Med 11:5389.

, ,

• Sarah MPG, Alexander RRP, Ines VR (2021) .Eur Heart J 42:4791-4801.

, ,

• Ya-Li H, Yong-Long G, Qian S (2022) .Front Cardiovasc Med 9:955734.

, ,

• Thais B, Bruno AdC, Vitor L (2023) .Ann Med 55:2217743.

, ,